Drug maker Aurobindo Pharma has said that it has received approvals
from US drug regulator for Stavudine capsules and Stavudine oral
solution, which are used in the treatment of HIV-1 infection. The
company has received nod from the US Food and Drug Administration
(USFDA) for Stavudine capsules and Stavudine for oral solution used for
treating HIV-1infection, Aurobindo Pharma said in a filing to the BSE.
Recently an application was filed under section 97 of the Central Goods and Services Tax Act, and the Maharashtra Goods and Services Tax Act, 2017 by lNA Bearing India Private Limited, being the More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More